Lilah Margaret Moorman serves as a Senior Veterinary Surgeon and Guest Researcher at the University of Copenhagen's Department of Veterinary Clinical Sciences, affiliated with both the Section for Diagnostic Imaging & Companion Animal Surgery and Clinical Specialties and the Section for Veterinary Imaging. Her clinical and research work centers on advancing diagnostic imaging techniques in veterinary medicine. Her research focuses on veterinary radiology applications, particularly hip dysplasia screening in companion animals through machine learning integration. Key interests include developing AI-driven solutions for radiographic analysis, creating soft tissue markers for image-guided therapy, and establishing quality standards for digital radiographs. This work bridges computational methods with clinical veterinary practice to enhance diagnostic precision in orthopedics and surgery. Analysis of her 2019-2021 publications reveals a consistent trend toward AI-enhanced veterinary imaging, with emphasis on deep transfer learning for joint detection/classification and multimodal markers connecting diagnostics to therapeutics. These studies demonstrate growing integration of computational intelligence in clinical veterinary workflows, particularly for improving hip dysplasia assessment accuracy and developing precision imaging tools.
Marie Bønnelycke serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her clinical affiliation with Region H (Copenhagen University Hospital) positions her at the intersection of academic research and clinical practice in pathology. Her institutional address is Blegdamsvej 3, 2200 København N, and she maintains research activity through the university's Institute of Clinical Medicine (ikm.ku.dk). Dr. Bønnelycke's research spans two primary domains: gynecological oncology (particularly endometrial cancer pathology) and biomedical engineering applications for surgical complications. Her work on lymphovascular space invasion has significantly contributed to endometrial cancer staging criteria, with multiple high-impact publications in journals like Gynecologic Oncology and International Journal of Gynecological Pathology . Simultaneously, she pioneers translational research on autologous blood-derived patches for preventing surgical adhesions and enhancing hemostasis, with innovative animal model studies published in journals including Journal of Materials Science: Materials in Medicine and Heliyon . Her publication portfolio demonstrates strong collaborative networks, particularly with researchers Eskildsen, Kalliokoski, and Loekkegaard. Several of her endometrial cancer studies have been referenced in clinical guidelines and have accumulated substantial citations (up to 75 in Scopus), indicating significant clinical impact. Her surgical biomaterials research shows promising translational potential, with studies demonstrating effectiveness in porcine and rat models across multiple organ systems. Dr. Bønnelycke maintains an active research trajectory with publications spanning 2022-2025, including a forthcoming 2025 study in Heliyon . Her work bridges laboratory research, animal models, and clinical application, reflecting a comprehensive approach to improving gynecological surgical outcomes and cancer diagnostics.
Min Zhang serves as Assistant Professor in the Department of Chemistry and Guest Researcher in the Department of Drug Design and Pharmacology within the Molecular and Cellular Pharmacology division at the University of Copenhagen's Faculty of Science. Based at Universitetsparken 5 and 2 in Copenhagen Ø, Zhang maintains an active research profile with 14 publications between 2023-2025. Research focuses on protein aggregation dynamics and advanced drug delivery systems , utilizing super-resolution microscopy and machine learning approaches. Key areas include insulin aggregation modulation, metal-organic framework (MOF) nanocarriers, and real-time observation of protein assembly pathways. Recent work develops computational tools like SEMORE for morphological fingerprinting of protein assemblies. Publication trends show strong interdisciplinary collaboration, particularly with N.S. Hatzakis' group, spanning biophysics, nanomedicine, and pharmaceutical sciences. Work has attracted significant attention with coverage by 12+ news outlets and 26+ X (Twitter) mentions. Zhang's scientific contributions include: Development of single-particle tracking methodologies for intracellular drug delivery Novel insights into insulin aggregation modulation by osmolytes Machine learning frameworks for super-resolution data analysis Defect-engineered MOF platforms for cancer therapeutics Active collaborations span molecular pharmacology, biophysics, and nanotechnology research groups. Current work focuses on real-time monitoring of protein aggregation pathways and advanced nanocarrier systems for pharmacotherapy.
Louise Laurberg Klarskov serves as Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her primary affiliation is with the Pathology unit at Copenhagen University Hospital (Region Hovedstaden), located at Blegdamsvej 3 in Copenhagen N. She maintains active clinical and research roles focused on molecular pathology of gastrointestinal malignancies. Her research concentrates on hereditary and molecular aspects of colorectal cancer, particularly Lynch syndrome surveillance, mismatch repair deficiency mechanisms, and genomic characterization of treatment-resistant tumors. Current investigations include pembrolizumab therapy for dMMR colorectal cancer and pancreatic cancer sequencing methodologies. Her work demonstrates strong translational focus with direct clinical implementation pathways. Analysis of her 16 research outputs (2021-2025) reveals consistent contributions to oncology journals including Anticancer Research , Translational Oncology , and Hereditary Cancer in Clinical Practice . Key thematic clusters include: (1) MMR deficiency screening implementation in Danish healthcare, (2) Molecular evolution of Lynch-associated cancers, (3) Genomic profiling of pancreatic and colorectal carcinomas, and (4) Diagnostic pathway optimization for abdominal conditions. Her collaborative network spans major Danish medical institutions including Rigshospitalet, Herlev Hospital, and Aarhus University Hospital, with international connections to European Lynch syndrome consortia. Notable policy impact includes referenced guidelines for universal MMR screening in colorectal cancer. Dr. Klarskov's clinical research directly informs national cancer screening protocols, particularly regarding colonoscopy surveillance intervals for mutation carriers and molecular testing standardization. Her work bridges laboratory genomics with clinical oncology practice through multicenter Danish registry studies and prospective therapeutic trials.
Kristian Steen Frederiksen serves as a Clinical Associate Professor at the University of Copenhagen's Department of Clinical Medicine and as a Senior Hospital Physician at Rigshospitalet's Department of Neurology. He is the director of the clinical trial unit at the Danish Dementia Research Centre (DDRC), where he leads drug intervention studies (phase I-IV) and clinical research in Alzheimer's disease, Huntington's disease, and related disorders. His work bridges academic research and clinical practice through a dual appointment with the Capital Region of Denmark and the University of Copenhagen. Dr. Frederiksen's research focuses on neurodegenerative dementia with particular emphasis on Alzheimer's disease and Lewy body dementia. His specific scientific focus includes biomarkers for early diagnostics and as outcome measures in intervention studies, investigation of pathophysiological mechanisms in neurodegenerative diseases, and the development of digital and imaging markers for clinical implementation. His work spans biomarker research, early disease manifestations, clinical applications, and digital innovation in dementia diagnostics. Analysis of his recent publications reveals a strong emphasis on diagnostic innovation, particularly in biomarker development for neurodegenerative diseases. His research integrates traditional biomarker approaches with digital health technologies and machine learning applications. A significant portion of his work addresses the implementation challenges of new therapies, particularly anti-amyloid treatments for Alzheimer's disease, reflecting his active role in European clinical guidelines development. Scientific Awards: Firkløver-fondens Hæderspris for Forskning 2025 (Firkløver Foundation Research Honor Prize) Dr. Frederiksen serves as Editor-in-Chief for Alzheimer's Research & Therapy (since June 2024) and has received substantial research funding from organizations including Alzheimer Forskningsfonden, Parkinsonforeningen, Innovation Fund Denmark, and industry partners. He acts as Principal or Sub-investigator and National Coordinator on multiple industry-sponsored phase 2 and 3 trials for Alzheimer's disease involving companies like Roche, Biogen, Novo Nordisk, and Eisai/Bioarctic. His extensive conflict of interest disclosures reflect his significant involvement in the dementia research ecosystem through editorial roles, advisory boards, and speaking engagements with major pharmaceutical companies. At the Danish Dementia Research Centre, Dr. Frederiksen leads a multidisciplinary team conducting cutting-edge research on dementia diagnostics and therapeutics. His clinical trial unit coordinates international studies while maintaining strong connections with European research networks including the European Alzheimer's Disease Consortium (EADC). His work bridges basic science, clinical application, and healthcare implementation, positioning him at the forefront of dementia research in Europe.
Svend Christensen is a Professor at the Department of Plant and Environmental Sciences, Faculty of Science, University of Copenhagen. He has held prominent positions at the Danish Institute of Agricultural Sciences (now Aarhus University), the University of Southern Denmark, and the University of Copenhagen. For 16 years, he served as a professor and head of the Department of Plant and Environmental Sciences with more than 500 employees. Currently, he is a full professor in Crop Science and Technologies. Education: Ph.D., The Royal Veterinary and Agricultural University, 1993 M.Sc. Agr., The Royal Veterinary and Agricultural University, 1988 Svend Christensen's research focuses on establishing the scientific foundation needed to transform agricultural systems to address the dual challenges of feeding a growing global population and preserving the planet's ecological balance. His work explores the interactions between crops and their environment, utilizing advanced technologies such as biologicals, breeding, remote sensing, AI, and robotics to promote sustainable farming practices. He is particularly known for his significant contributions to understanding crop-weed competition and developing weed sensing and site-specific weed management technologies that have advanced precision agriculture globally. His recent publications demonstrate a strong trend toward integrating cutting-edge technologies with traditional agricultural science. The research shows increasing sophistication in plant phenotyping, with a particular emphasis on high-throughput systems, hyperspectral imaging, and AI-driven analysis. There's a clear interdisciplinary approach connecting plant science, data science, and engineering to develop innovative solutions for crop management, disease resistance, and resource efficiency in agricultural systems. Notable Projects: MATRIX project funded by the Novo Nordisk Foundation Nordic Public Private Partnership Plant Phenotyping Project Professor Christensen actively leads several high-impact collaboration platforms including Crop Innovation Denmark (involving four breeding companies and two universities), the Nordic-Baltic Plant Phenotyping Network (with more than 15 breeding companies, universities, and research organizations), and the Plant Biologicals Network (comprising more than 20 members from industries and universities in Denmark and Sweden). His leadership extends to numerous professional activities including service on the Danish Research Council for Technology and Production (2007-2013), coordination of the Collaborative Working Group on 'ICT and Robotics in Agriculture' under the European Commission, and participation in various expert groups related to agricultural technology and policy development.
Lasse Møller-Jensen serves as Professor in the Department of Geosciences and Natural Resource Management at the University of Copenhagen's Faculty of Science, specializing in urban applications of GIS and remote sensing with emphasis on developing regions. His three-decade fieldwork spans Ghana, Tanzania, Senegal, Mongolia, Thailand, and Vietnam. Educational background: Ph.D, University of Copenhagen 1993 (Urban Geography/Geoinformatics) MSc degree, University of Copenhagen 1989 (Human Geography) BSc degree, University of Copenhagen 1989 (Computer Science) BSc degree, University of Copenhagen 1985 (Human Geography) His research integrates geoinformatics with urban planning challenges in resource-constrained settings, focusing on flood risk modeling, transportation infrastructure analysis, and satellite image processing. Recent work leverages UAV and LiDAR technologies for high-resolution urban flood assessment, particularly in Accra. Publications since 2020 reveal a concentrated focus on climate-driven urban mobility disruptions in African cities, with methodological innovations in remote sensing for flood risk mapping and urban expansion analysis. Over 30% of recent output addresses Accra's flooding challenges through interdisciplinary collaborations. Supervision and funding: Advised 50+ master's students and 8 PhD candidates (Denmark/Ghana) Principal Investigator for Climate Change Resilience in Urban Mobility (FFU, DKK 9.8M, 2018-2023) Lead for Future of Urban Tanzania project (Strategic Research Council, 2010-2013) EU-funded RurbanAfrica collaboration (2012-2016) Danida-FFU consultant for Agricultural Growth project (2011-2014) He directed the Cities, Landscapes and Geoinformatics research group (2009-2012) and the Geography Section (2012-2016), maintaining active capacity-building partnerships with African institutions through WANSEC and Enreca initiatives.
Jacob Høygaard Rasmussen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on head and neck oncology, particularly HPV-mediated oropharyngeal cancers, with extensive work on cancer staging, prognosis, and diagnostic imaging techniques. Dr. Rasmussen's research interests center on the epidemiology, diagnosis, and treatment of head and neck cancers, with particular emphasis on HPV-related oropharyngeal carcinoma. His work explores the prognostic implications of various biomarkers including p16 and HPV status, cancer staging systems, and the application of advanced imaging techniques like 3D ultrasound and MRI for surgical planning. His research bridges clinical practice with epidemiological analysis, examining trends in cancer incidence and outcomes across different populations. His publication record demonstrates a strong focus on head and neck cancer research with particular attention to HPV-related oropharyngeal cancers. His recent work examines the accuracy of radiologic imaging for assessing cancer spread, risk stratification models for clinical trials, international comparisons of cancer outcomes, and the epidemiological trends of oropharyngeal cancer in high HPV-prevalence regions. His research frequently involves large-scale, multinational collaborations such as the Head and Neck Cancer International Group (HNCIG). Dr. Rasmussen's work has garnered significant attention in the scientific community, with multiple publications receiving substantial citations and media coverage. His 2023 Lancet Oncology paper on p16 and HPV discordance in oropharyngeal cancer has been particularly influential, with over 180 citations, mentioned in news outlets, social media, Wikipedia pages, and clinical guidelines. His research activities include participation in clinical diagnostic accuracy studies examining 3D ultrasound and MRI for assessing resection margins during tongue cancer surgery, as well as investigations into the clinical implications of genetic intratumor heterogeneity for targeted therapy in head and neck cancer. His collaborative work spans multiple institutions across Denmark and internationally, reflecting the global significance of his research in the field of head and neck oncology.
Rigmor Højland Jensen is a Clinical Associate Professor at the Faculty of Health and Medical Sciences, University of Copenhagen, specializing in headache disorders within the Department of Clinical Medicine, Neurology. With over 200 types of headaches in her expertise, including tension headaches, migraines, cluster headaches, and various chronic pain disorders, she is a recognized authority in neurological pain management. Her educational background includes specialized training as a Master of Headache Disorders. Dr. Jensen's research focuses on headache pathophysiology, biomarker discovery, and innovative treatment approaches for various headache disorders. Her research portfolio includes approximately 310 publications, with recent work focusing on intracranial hypertension, cluster headache mechanisms, and novel treatment approaches. Her 2024-2025 publications demonstrate a strong emphasis on biomarker research, particularly investigating neuropeptides like $$\text{PACAP-38}$$ and $$\text{Calcitonin gene-related peptide}$$ in headache disorders, as well as evaluating diagnostic criteria and treatment mechanisms for conditions like idiopathic intracranial hypertension. Her work has been cited in various academic platforms and disseminated through social media channels including X (formerly Twitter), Facebook, and academic platforms like Mendeley. Dr. Jensen leads research initiatives examining the relationship between neurological structures (such as pineal cysts), intracranial pressure disorders, and headache manifestations. Her clinical expertise informs both her research direction and patient care approaches in headache medicine.
Jeppe Lohfert Haslund-Vinding serves as an External Lecturer in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on the molecular characterization of meningiomas, particularly investigating biomarkers, tumor microenvironment, and clinical correlations. His research interests center on neuro-oncology with specific emphasis on meningioma biology. His work spans multiple domains including molecular pathology, tumor immunology, epigenetic regulation, and clinical-translational research. He has developed expertise in flow cytometry analysis of tumor immune composition, DNA methylation profiling, and gene expression analysis in meningioma progression. Analysis of his recent publications reveals a strong trend toward translational research connecting molecular markers with clinical outcomes in meningioma patients. His work demonstrates increasing sophistication in molecular techniques while maintaining clinical relevance, with particular focus on immune cell composition, epigenetic markers, and developing diagnostic and prognostic tools for meningioma management. His research collaborations span multiple departments and institutions, working closely with neurosurgical teams, pathology departments, and basic science researchers. His work appears to be supported by institutional funding from the University of Copenhagen and likely Danish health research councils, though specific grant details aren't provided in the available text. Dr. Haslund-Vinding is actively involved in the Copenhagen meningioma research group, contributing to the development of the Copenhagen grading system for meningiomas. His laboratory work focuses on molecular analysis of meningioma tissue samples, with particular expertise in flow cytometry protocols optimized for brain tumor samples and epigenetic analysis of meningeal tissues.
Jane Skjøth serves as Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Neurosurgery. Her clinical and research activities are centered at Copenhagen University Hospital (Region Hovedstaden) where she maintains an active neurosurgical practice focusing on brain tumor management. Her research program spans multiple critical areas in neuro-oncology, with emphasis on glioblastoma immunotherapy , intraoperative imaging techniques , and blood-brain barrier dynamics . Current projects include developing novel optical imaging agents for fluorescence-guided glioma resection and investigating immune checkpoint inhibitor mechanisms in recurrent glioblastoma. Her work integrates translational approaches from proteomic analysis of cerebrospinal fluid to first-in-human surgical imaging trials. Analysis of her recent publication portfolio reveals strong focus on translational neurosurgical oncology , particularly in three interconnected domains: (1) Advanced intraoperative visualization techniques for tumor resection, (2) Immunological mechanisms and therapeutic responses in glioblastoma, and (3) Metabolic and physiological monitoring during brain tumor surgery. Her collaborative network spans neurosurgery, oncology, and molecular imaging disciplines across Danish and international institutions. While specific mentoring activities aren't detailed in available sources, her leadership in first-in-human surgical imaging trials and multi-institutional glioblastoma cohort studies indicates active supervision of clinical researchers. Her work has attracted significant scientific attention with multiple publications picked up by news outlets and substantial academic readership.
